​

Senti Biosciences (SNTI) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Senti Biosciences Revenue Highlights

Latest Revenue (Y)

$2.56M

0

Main Segment (Y)

License

Senti Biosciences Revenue by Period

Senti Biosciences Revenue by Year

DateRevenueChange
2023-12-31$2.56M-40.25%
2022-12-31$4.29M87.08%
2021-12-31$2.29M481.47%
2020-12-31$394.00K363.53%
2019-12-31$85.00K-

Senti Biosciences generated $2.56M in revenue during NA 2023, up -40.25% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Senti Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$333.00K30.59%
2023-09-30$255.00K-72.79%
2023-06-30$937.00K-9.56%
2023-03-31$1.04M1655.93%
2022-12-31$59.00K-96.66%
2022-09-30$1.77M59.39%
2022-06-30$1.11M29.74%
2022-03-31$854.00K57.27%
2021-12-31$543.00K-41.36%
2021-09-30$926.00K19.02%
2021-06-30$778.00K980.56%
2021-03-31$72.00K3500.00%
2020-12-31$2.00K-

Senti Biosciences generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Senti Biosciences Revenue Breakdown

Senti Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22
License$800.00K

Senti Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 22: License (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 23Mar 23
License$200.00K$400.00K

Senti Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: License (100.00%).

Senti Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LIPOLipella Pharmaceuticals$449.62M$80.38M
FHTXFoghorn Therapeutics$34.16M$7.81M
FENCFennec Pharmaceuticals$21.64M$6.97M
SNTISenti Biosciences$2.56M-
SABSSAB Biotherapeutics$2.24M$263.14K
RAPTRAPT Therapeutics--
CNTBConnect Biopharma--
CINGCingulate--
CVKDCadrenal Therapeutics--
MLYSMineralys Therapeutics--
MNPRMonopar Therapeutics--
QNRXQuoin Pharmaceuticals--
TYRATyra Biosciences--
XLOXilio Therapeutics-$2.36M

SNTI Revenue FAQ

What is Senti Biosciences’s yearly revenue?

Senti Biosciences's yearly revenue for 2023 was $2.56M, representing a decrease of -40.25% compared to 2022. The company's yearly revenue for 2022 was $4.29M, representing an increase of 87.08% compared to 2021. SNTI's yearly revenue for 2021 was $2.29M, representing an increase of 481.47% compared to 2020.

What is Senti Biosciences’s quarterly revenue?

Senti Biosciences's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). SNTI's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

What is Senti Biosciences’s revenue growth rate?

Senti Biosciences's revenue growth rate for the last 3 years (2021-2023) was 11.79%, and for the last 5 years (2019-2023) was 2912.94%.

What are Senti Biosciences’s revenue streams?

Senti Biosciences's revenue streams in c 22 are License

What is Senti Biosciences’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Senti Biosciences was License. This segment made a revenue of $800K, representing 100.00% of the company's total revenue.